SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-acquisition-2026-4
acquisitionAnnounced · Mar 6, 2026biopharmaSource · CredibleArticle · Factual
Servier acquires Day One Biopharma
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$2.5B
Target
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier
Full Acquisition
Status
Announced
Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Announced. Sector: biopharma. Target headquarters context: Brisbane, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.
The French pharma company Servier said Friday that it would buy Day One Biopharmaceuticals , the maker of a drug for childhood brain tumors, in a deal worth roughly $2.5 billion
Deal timeline
Announced
Mar 6, 2026 · statnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharma with a reported deal value of $2.5B. Figures and status may change as sources update.
Sources: statnews.com · Primary article · FireStrike proprietary index